Under construction – not a live service
Sign in

Type 1 diabetes trials, also abroad

539 open Type 1 diabetes trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States216
Canada51
France43
China40
Denmark35
All other countries

The same trial often runs in several countries

Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? has 1 site in Qatar and runs in 3 countries. If a site near you is full, another one may still take people.

See Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration? in all 3 countries